Small peptide TAT-AVPY for treating ischemic brain damage, and application thereof
A TAT-AVPY, ischemic brain injury technology, applied in the medical field, can solve problems such as reducing the activation of caspase-3, and achieve the effects of reducing apoptosis, reducing activation, and facilitating drug delivery
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] In the embodiment of the present invention, a small peptide TAT-AVPY for the treatment of ischemic brain injury, wherein TAT is an 11-amino acid sequence YGRKKRRQRRR on the lentivirus, and AVPY is based on blocking the relationship between procaspase-9 and XIAP in brain ischemia It is designed to increase binding and transnitrosylation after blood and reperfusion. The full sequence of the small peptide TAT-AVPY is: H-YGRKKRRQRRR-AVPY-OH, as shown in SEQ ID NO:1.
[0024] After cerebral ischemia, endogenous procaspase-9 undergoes denitrosylation and hydrolytic activation, leading to cell apoptosis. The activity of Caspases is regulated by Inhibitors of Apoptosis (IAPs), among which X-linked Inhibitors of Apoptosis (XIAP) directly binds to procaspase-9 through its BIR domain and inhibits its activity. After cerebral ischemia, XIAP undergoes nitrosylation, thereby inhibiting its own anti-apoptotic activity.
[0025] According to the amino acid sequence of the binding site b...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com